GlassScriptPhysician profile
Brett A Bowie
NPI 1215026646
$6,003.35
in general payments reported to CMS, 2019-2025
24 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $53.88 · 2021: $43.87 · 2022: $5,080 · 2023: $356 · 2024: $195 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,185.00 | 2022-2025 | Da Vinci Surgical System |
| Abbvie INC. | $188.70 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $104.77 | 2023-2025 | Myfembree |
| Pfizer INC. | $88.80 | 2022-2023 | |
| Astellas Pharma US INC | $57.50 | 2023-2024 | Veozah |
| Optumhealth Care Solutions, LLC | $42.79 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Boston Scientific Corporation | $38.21 | 2022-2024 | Solyx Sis System |
| Hologic Sales and Service, LLC | $33.99 | 2019-2020 | |
| Coloplast Corp | $26.90 | 2024 | |
| Therapeuticsmd, INC. | $23.03 | 2019 | |
| Biogen, INC. | $21.04 | 2024 | |
| Exeltis, USA INC. | $20.51 | 2023 | Slynd |
| Organon LLC | $19.29 | 2022 | |
| Coopersurgical, INC. | $15.87 | 2023 | Summit Doppler |
| Mylan Pharmaceuticals INC. | $15.72 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $14.84 | 2021 | |
| Meditrina | $14.61 | 2024 | |
| Novo Nordisk INC | $14.03 | 2023 | Wegovy |
| Lupin INC. | $14.01 | 2019 | |
| Heron Therapeutics, INC. | $13.99 | 2023 | Zynrelef |
| Agile Therapeutics, INC. | $13.31 | 2021 | |
| Myovant Sciences INC. | $12.85 | 2022 | |
| Avion Pharmaceuticals | $11.90 | 2022 | |
| Allergan, INC. | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Bowie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.